← Mechanisms of action
CNR2
SINGLE PROTEINHomo sapiens
Preferred name: Cannabinoid CB2 receptor ChEMBL ↗
Linked proteins
Drugs acting on this target (20)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| apd371 | Agonist | experimental | Small molecule | CNR2 agonist |
| cntx-6016 | Agonist | experimental | Small molecule | CNR2 agonist |
| gw842166 | Agonist | experimental | Small molecule | CNR2 agonist |
| jbt-101 | Agonist | experimental | Small molecule | CNR2 agonist |
| jw0108 | Agonist | experimental | Small molecule | CNR2 agonist |
| jwh018 | Agonist | experimental | Small molecule | CNR2 agonist |
| ly2828360 | Agonist | experimental | Small molecule | CNR2 agonist |
| nonabine | Agonist | experimental | Small molecule | CNR2 agonist |
| ntrx-07-sdd | Agonist | experimental | Small molecule | CNR2 agonist |
| oct461201 | Agonist | experimental | Small molecule | CNR2 agonist |
| org 28611 | Agonist | experimental | Small molecule | CNR2 agonist |
| prs-211375 | Agonist | experimental | Small molecule | CNR2 agonist |
| s-777469 | Agonist | experimental | Small molecule | CNR2 agonist |
| sad-448 | Agonist | experimental | Small molecule | CNR2 agonist |
| tedalinab | Agonist | experimental | Small molecule | CNR2 agonist |
| Vicasinabin | Agonist | experimental | Small molecule | CNR2 agonist |
| tak-816 | Antagonist | experimental | Vaccine | CNR2 antagonist |
| tt-816 | Antagonist | experimental | Small molecule | CNR2 antagonist |
| lactic acid | Other | approved | Small molecule | CNR2 other |
| [18f]-rosma-18-d6 | Radiopharmaceutical | experimental | Small molecule | CNR2 radiopharmaceutical |